Skip to main content
Erschienen in: Head and Neck Pathology 1/2011

01.03.2011 | Case Report

The Spectrum of Gnathic Osteosarcoma: Caveats for the Clinician and the Pathologist

verfasst von: Ricardo J. Padilla, Valerie A. Murrah

Erschienen in: Head and Neck Pathology | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Seven expansile jaw lesions in patients ranging from 7 to 63 years are presented to illustrate diagnostic and management issues pertaining to cases ultimately proven to be gnathic osteosarcoma (GO). Six of the cases in our series were low-grade osteoblastic and one high-grade chondroblastic. None of our cases exhibited the characteristic “sunburst” radiopaque appearance described for GO. All of our cases displayed cortical expansion and one showed development of diastema. Two occurred in the maxilla and five in the mandible. Two of the patients with mandibular lesions presented initially with pain; all other patients were asymptomatic. Lack of pain resulted in a delay in diagnosis due to postponement of consultation or biopsy. Two cases underwent initial shallow non-representative biopsies, requiring a second biopsy for definitive diagnosis, further delaying treatment. Those biopsies were initially interpreted as pyogenic granuloma and peripheral ossifying fibroma, respectively. GO should always be considered in the differential diagnosis of expansile jaw lesions. Bone biopsies of lesions exhibiting pain and expansion of cortical plates should include medullary bone in order to minimize sampling error. In addition, all rapidly growing or painful exophytic bone lesions, and presumed soft tissue lesions that may involve underlying bone, should be examined histopathologically, and receive clinical and radiographic follow-up until complete resolution or healing is evident, regardless of the diagnosis. Based on the positive outcomes of the patients in our series, the prognosis of GO appears to be relatively favorable when compared to other sarcomas and osteosarcomas of long bones.
Literatur
1.
Zurück zum Zitat Fletcher CDM, Unni KK, Mertens F, editors. World Health Organization classification of tumors. Pathology and genetics of tumors of soft tissue and bone. Lyon: IARC Press; 2002. Fletcher CDM, Unni KK, Mertens F, editors. World Health Organization classification of tumors. Pathology and genetics of tumors of soft tissue and bone. Lyon: IARC Press; 2002.
2.
Zurück zum Zitat Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005. Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005.
3.
Zurück zum Zitat Fernandez R, Nikitakis NG, Pazoli A, Ord RA. Osteogenic sarcoma of the jaw: a 10-year experience. J Oral Maxillofac Surg. 2007;65(7):1286–91.CrossRef Fernandez R, Nikitakis NG, Pazoli A, Ord RA. Osteogenic sarcoma of the jaw: a 10-year experience. J Oral Maxillofac Surg. 2007;65(7):1286–91.CrossRef
4.
Zurück zum Zitat Cheng YS, Wright JM, Walstad WR, Finn MD. Osteosarcoma arising in Paget’s disease of the mandible. Oral Oncol. 2002;38(8):785–92.CrossRefPubMed Cheng YS, Wright JM, Walstad WR, Finn MD. Osteosarcoma arising in Paget’s disease of the mandible. Oral Oncol. 2002;38(8):785–92.CrossRefPubMed
5.
Zurück zum Zitat Bramer JA, Abdulu AA, Tillman RM, Carter SR, Sumathi VP, Grimer RJ. Pre- and post-chemotherapy alkaline phosphatase levels as prognostic indicators in adults with localised osteosarcoma. Eur J Cancer. 2005;41(18):2846–52.CrossRefPubMed Bramer JA, Abdulu AA, Tillman RM, Carter SR, Sumathi VP, Grimer RJ. Pre- and post-chemotherapy alkaline phosphatase levels as prognostic indicators in adults with localised osteosarcoma. Eur J Cancer. 2005;41(18):2846–52.CrossRefPubMed
6.
Zurück zum Zitat Nissanka EH, Amaratunge EA, Tilakaratne WM. Clinicopathological analysis of osteosarcoma of jaw bones. Oral Dis. 2007;13(1):82–7.CrossRefPubMed Nissanka EH, Amaratunge EA, Tilakaratne WM. Clinicopathological analysis of osteosarcoma of jaw bones. Oral Dis. 2007;13(1):82–7.CrossRefPubMed
7.
Zurück zum Zitat Guadagnolo BA, Zagars GK, Raymond AK, Benjamin RS, Sturgis EM. Osteosarcoma of the jaw/craniofacial region: outcomes after multimodality treatment. Cancer. 2009;115(14):3262–70.CrossRefPubMed Guadagnolo BA, Zagars GK, Raymond AK, Benjamin RS, Sturgis EM. Osteosarcoma of the jaw/craniofacial region: outcomes after multimodality treatment. Cancer. 2009;115(14):3262–70.CrossRefPubMed
8.
Zurück zum Zitat Niswander LM, Kim SY. Stratifying osteosarcoma: minimizing and maximizing therapy. Curr Oncol Rep. 2010;12(4):266–70.CrossRefPubMed Niswander LM, Kim SY. Stratifying osteosarcoma: minimizing and maximizing therapy. Curr Oncol Rep. 2010;12(4):266–70.CrossRefPubMed
9.
Zurück zum Zitat Eftekhari F. Imaging assessment of osteosarcoma in childhood and adolescence: diagnosis, staging, and evaluating response to chemotherapy. Cancer Treat Res. 2010;152:33–62.CrossRef Eftekhari F. Imaging assessment of osteosarcoma in childhood and adolescence: diagnosis, staging, and evaluating response to chemotherapy. Cancer Treat Res. 2010;152:33–62.CrossRef
10.
Zurück zum Zitat Bennett JH, Thomas G, Evans AW, Speight PM. Osteosarcoma of the jaws: a 30-year retrospective review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90(3):323–32.CrossRefPubMed Bennett JH, Thomas G, Evans AW, Speight PM. Osteosarcoma of the jaws: a 30-year retrospective review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90(3):323–32.CrossRefPubMed
11.
Zurück zum Zitat Givol N, Buchner A, Taicher S, Kaffle I. Radiological features of osteogenic sarcoma of the jaws. A comparative study of different radiographic modalities. Dentomaxillofac Radiol. 1998;27(6):313–20.CrossRefPubMed Givol N, Buchner A, Taicher S, Kaffle I. Radiological features of osteogenic sarcoma of the jaws. A comparative study of different radiographic modalities. Dentomaxillofac Radiol. 1998;27(6):313–20.CrossRefPubMed
12.
Zurück zum Zitat Vencio EF, Reeve CM, Unni KK, Nascimento AG. Mesenchymal chondrosarcoma of the jaw bones: clinicopathologic study of 19 cases. Cancer. 1998;82(12):2350–5.CrossRefPubMed Vencio EF, Reeve CM, Unni KK, Nascimento AG. Mesenchymal chondrosarcoma of the jaw bones: clinicopathologic study of 19 cases. Cancer. 1998;82(12):2350–5.CrossRefPubMed
Metadaten
Titel
The Spectrum of Gnathic Osteosarcoma: Caveats for the Clinician and the Pathologist
verfasst von
Ricardo J. Padilla
Valerie A. Murrah
Publikationsdatum
01.03.2011
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 1/2011
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-010-0218-y

Weitere Artikel der Ausgabe 1/2011

Head and Neck Pathology 1/2011 Zur Ausgabe

Proceedings of the NASHNP Companion Meeting, February, 2011, San Antonio, TX

A Review of NUT Midline Carcinoma

Proceedings of the NASHNP Companion Meeting, February, 2011, San Antonio, TX

Papillary Thyroid Carcinoma Variants

Sine qua none Radiology-Pathology

Squamous Odontogenic Tumor

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …